Skip to search formSkip to main contentSkip to account menu

Lyspafen

Known as: 4-Piperidinecarboxylic acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, mixt. with endo-(+-)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl alpha-(hydroxymethyl)benzeneacetate sulfate (2:1) (salt) 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

AtropineDiphenoxylateDrug Combinations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
New antidiarrhoeal agent. Lyspafen tablets.
1979
1979
[Double-blind study on the influence of difenoxin hydrochloride on intestinal passage time in healthy volunteers (author's transl)].
The effect on the intestinal passage of 3 X 1 mg difenoxin hydrochloride (Lyspafen) was tested in a randomised double-blind study… 
1979
1979
[Treatment of diarrhea with difenoxin hydrochloride in children (author's transl)].
In an open clinical study symptomatic treatment was given to 93 children aged 16 days to 24 months who suffered from acute… 
1979
1979
[Lyspafen and acute diarrhoe in pediatry (author's transl)].
1976
1976
[Stomach motility and lyspafen].
Studies of motility of the stomach in 10 test-persons resulted in a significant reduction of motility after a 2-day period of… 
1960
1960
[Lyspafen in obstetrics].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)